Cargando…

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid

BACKGROUND: In medical applications of radioisotopes, for calculations of whole body doses and radiation safety applications, there is a need to estimate radioactive body burden. Local recommendations in Oman stipulate the need for hospitalization of patients treated for radioactive-iodine ((131) I)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravichandran, R, Binukumar, JP, Saadi, Amal Al
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003283/
https://www.ncbi.nlm.nih.gov/pubmed/21188063
http://dx.doi.org/10.4103/0972-3919.72686
_version_ 1782193852072853504
author Ravichandran, R
Binukumar, JP
Saadi, Amal Al
author_facet Ravichandran, R
Binukumar, JP
Saadi, Amal Al
author_sort Ravichandran, R
collection PubMed
description BACKGROUND: In medical applications of radioisotopes, for calculations of whole body doses and radiation safety applications, there is a need to estimate radioactive body burden. Local recommendations in Oman stipulate the need for hospitalization of patients treated for radioactive-iodine ((131) I) with activities above 400 MBq. MATERIALS & METHODS: A study of body burden estimation from sequentially measured exposure rates from patients treated for carcinoma thyroid and hyperthyroidism was undertaken. A digital auto-ranging beta gamma survey instrument calibrated for measurement of exposure rates is used in this study. RESULTS: The mean measured exposure rates at 1 m in μSv/h immediately after administration and at 24 h intervals are used for estimation of effective half time of clearance of administered activity. For patients with post-operative thyroid carcinoma, the variation of body burden with time post-administration indicated tri-exponential clearance pattern, with T(½eff) values 14.4 h, 22 h, and 41.3 h. For patients treated for thyrotoxicosis, the body burden showed slow delayed clearance with a T(½eff) – 111.4 h, and exposure rates did not show appreciable fall off after 48 h.
format Text
id pubmed-3003283
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30032832010-12-23 Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid Ravichandran, R Binukumar, JP Saadi, Amal Al Indian J Nucl Med Original Article BACKGROUND: In medical applications of radioisotopes, for calculations of whole body doses and radiation safety applications, there is a need to estimate radioactive body burden. Local recommendations in Oman stipulate the need for hospitalization of patients treated for radioactive-iodine ((131) I) with activities above 400 MBq. MATERIALS & METHODS: A study of body burden estimation from sequentially measured exposure rates from patients treated for carcinoma thyroid and hyperthyroidism was undertaken. A digital auto-ranging beta gamma survey instrument calibrated for measurement of exposure rates is used in this study. RESULTS: The mean measured exposure rates at 1 m in μSv/h immediately after administration and at 24 h intervals are used for estimation of effective half time of clearance of administered activity. For patients with post-operative thyroid carcinoma, the variation of body burden with time post-administration indicated tri-exponential clearance pattern, with T(½eff) values 14.4 h, 22 h, and 41.3 h. For patients treated for thyrotoxicosis, the body burden showed slow delayed clearance with a T(½eff) – 111.4 h, and exposure rates did not show appreciable fall off after 48 h. Medknow Publications 2010 /pmc/articles/PMC3003283/ /pubmed/21188063 http://dx.doi.org/10.4103/0972-3919.72686 Text en © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ravichandran, R
Binukumar, JP
Saadi, Amal Al
Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
title Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
title_full Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
title_fullStr Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
title_full_unstemmed Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
title_short Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
title_sort estimation of effective half life of clearance of radioactive iodine ((131)i) in patients treated for hyperthyroidism and carcinoma thyroid
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003283/
https://www.ncbi.nlm.nih.gov/pubmed/21188063
http://dx.doi.org/10.4103/0972-3919.72686
work_keys_str_mv AT ravichandranr estimationofeffectivehalflifeofclearanceofradioactiveiodine131iinpatientstreatedforhyperthyroidismandcarcinomathyroid
AT binukumarjp estimationofeffectivehalflifeofclearanceofradioactiveiodine131iinpatientstreatedforhyperthyroidismandcarcinomathyroid
AT saadiamalal estimationofeffectivehalflifeofclearanceofradioactiveiodine131iinpatientstreatedforhyperthyroidismandcarcinomathyroid